US Equity · NASDAQ · Earnings Dossier

LEXX earnings intelligence

Lexaria Bioscience Corp

Healthcare · Biotechnology · USD reporting basis

Current earnings profile Mixed earnings transmission

Delivery and market response do not currently form a persistent directional pattern.

Evidence100/100 · Deep

Next scheduled catalyst

No forward date is currently stored

The historical dossier remains available while the next calendar date is unconfirmed.

0event risk

Inactive

Countdown-calendar proximity
EPS estimate-provider consensus
Estimate growth-versus comparable year-ago actual
Historical movement7.2%average absolute next weekly close

Three-year earnings transmission

Delivered earnings power versus market price

Three-year relationship unavailable

Earnings power must be positive at the start of the three-year window.

Beat rate50.0%6 beats in 12 measured quarters
Average surprise-7.6%median -6.0%
Delivery streak11 consecutive misses
Average response-1.0%12 measured reactions
Result-price confirmation67%same directional sign
Surprise variability31.3 ptspopulation dispersion

Estimate delivery

Actual EPS versus consensus

Actual and estimated EPS are displayed in reported currency on the same quarterly basis.

Price acceptance

Surprise and next weekly close

The response uses the first completed weekly close after the public report against the prior completed weekly close.

Fundamental delivery

Quarterly revenue and net income

Reported financial statements provide scale and earnings quality context around the headline EPS result.

Transmission matrix

Does price confirm delivery?

Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.

Current business context

Growth, quality and valuation

As of 9 Aug 2026
EPS growth-year on year
Revenue growth-68.5%year on year
Average surprise9.2%latest four quarters
SUE-0.29standardised surprise
Net margin-3985.6%trailing basis
Cash conversion0.94xcash flow / net income
P/E-current snapshot
Data completeness79%alphavantage

Market context

Positioning into the event

Week ending 7 Aug 2026
Weekly close5.27 USDcompleted week
13-week return-42.4%price momentum
Fair-value gap-78.3%price versus current fair value
Relative strength-61.9exchange benchmark
Trend signalInactiveweekly architecture
Next-week stateNegative44.0%

Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.

Reported evidence ledger

Quarter-by-quarter delivery and acceptance

Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.

12 quarters
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / period13 Jul 202631 May 2026 · exact
EPS actual / estimate-0.08 / -0.06USD
Surprise-33.3%Miss
EPS growth+61.9%year on year
Revenue / growth0-100.0% · USD
Next close / four weeks-1.6% / -45.7%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period13 Apr 202628 Feb 2026 · exact
EPS actual / estimate-0.06 / -0.07USD
Surprise+14.3%Beat
EPS growth+60.0%year on year
Revenue / growth20000-88.5% · USD
Next close / four weeks+13.2% / -33.0%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period13 Jan 202630 Nov 2025 · exact
EPS actual / estimate-0.07 / -0.13USD
Surprise+46.2%Beat
EPS growth+56.2%year on year
Revenue / growth0-100.0% · USD
Next close / four weeks+1.7% / -2.8%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period26 Nov 202531 Aug 2025 · exact
EPS actual / estimate-0.14 / -0.16USD
Surprise+9.7%Beat
EPS growth+6.7%year on year
Revenue / growth174000+107.1% · USD
Next close / four weeks+3.8% / -44.5%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period14 Jul 202531 May 2025 · exact
EPS actual / estimate-0.21 / -0.14USD
Surprise-50.0%Miss
EPS growth-61.5%year on year
Revenue / growth174000+107.1% · USD
Next close / four weeks+7.3% / -4.1%completed weekly closes
ReadDivergedresult versus price sign
Reported / period14 Apr 202528 Feb 2025 · exact
EPS actual / estimate-0.15 / -0.16USD
Surprise+6.2%Beat
EPS growth-150.0%year on year
Revenue / growth174000+20.0% · USD
Next close / four weeks+2.2% / -20.0%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period10 Jan 202530 Nov 2024 · exact
EPS actual / estimate-0.16 / -0.12USD
Surprise-33.3%Miss
EPS growth-23.1%year on year
Revenue / growth183923+21.6% · USD
Next close / four weeks-17.0% / -22.7%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period26 Nov 202431 Aug 2024 · exact
EPS actual / estimate-0.15 / -0.11USD
Surprise-36.4%Miss
EPS growth-25.0%year on year
Revenue / growth84000+2546.8% · USD
Next close / four weeks-0.5% / +6.7%completed weekly closes
ReadContainedresult versus price sign
Reported / period12 Jul 202431 May 2024 · exact
EPS actual / estimate-0.13 / -0.09USD
Surprise-44.4%Miss
EPS growth-year on year
Revenue / growth84000- · USD
Next close / four weeks0.0% / +37.0%completed weekly closes
ReadContainedresult versus price sign
Reported / period9 Apr 202429 Feb 2024 · exact
EPS actual / estimate-0.06 / -0.10USD
Surprise+40.0%Beat
EPS growth-year on year
Revenue / growth145000- · USD
Next close / four weeks-30.5% / +2.6%completed weekly closes
ReadDivergedresult versus price sign
Reported / period12 Jan 202430 Nov 2023 · exact
EPS actual / estimate-0.13 / -0.11USD
Surprise-18.2%Miss
EPS growth-year on year
Revenue / growth151278- · USD
Next close / four weeks+8.9% / +28.9%completed weekly closes
ReadDivergedresult versus price sign
Reported / period21 Nov 202331 Aug 2023 · exact
EPS actual / estimate-0.12 / -0.13USD
Surprise+7.7%Beat
EPS growth-year on year
Revenue / growth-3433- · USD
Next close / four weeks+0.0% / -3.0%completed weekly closes
ReadContainedresult versus price sign

Reproducible method

How the earnings dossier is measured

Descriptive, not predictive
Estimate delivery

Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.

Price response

The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.

Event risk

Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.

Data discipline

Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.

Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.

Evidence context